FENC

Fennec Pharmaceuticals (FENC)

About Fennec Pharmaceuticals (FENC)

Fennec Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of PEDMARK to reduce the risk of platinum-induced ototoxicity in pediatric patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Details

Daily high

$7.64

Daily low

$7.54

Price at open

$7.62

52 Week High

$9.92

52 Week Low

$4.68

Market cap

257.4M

Dividend yield

0.00%

Volume

25,931

Avg. volume

161,675

P/E ratio

-31.68

Fennec Pharmaceuticals News